Versant Ventures IV LLC 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 07:33 am Purchase | 2020-09-29 | 13D | CRISPR Therapeutics AG CRSP | Versant Ventures IV LLC | 1,344,010 1.900% | 1,344,010 (New Position) | Filing |